Compare BUR & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BUR | INSP |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | Guernsey | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2017 | 2018 |
| Metric | BUR | INSP |
|---|---|---|
| Price | $4.15 | $45.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $13.58 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 2.0M | 823.6K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $413,360,000.00 | $82,050,000.00 |
| Revenue This Year | $104.62 | $8.02 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $3.59 | $38.91 |
| 52 Week High | $14.61 | $147.03 |
| Indicator | BUR | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 56.56 |
| Support Level | $3.59 | $39.42 |
| Resistance Level | $4.81 | $58.45 |
| Average True Range (ATR) | 0.21 | 2.00 |
| MACD | -0.01 | 0.62 |
| Stochastic Oscillator | 18.25 | 95.02 |
Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.